Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case-control study.
Authors: Flower v
Date: 21 Feb 2023
Scope of interest: infectious diseases/penitentiary health
Authors: Flower v
Date: 21 Feb 2023
Scope of interest: infectious diseases/penitentiary health
Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.
Date: 2022
Scope of interest: Epilepsy
Authors: Ivory F, Cerulli Irelli E, Morano A, Fanella M, Orlando B, Albini M, Basili LM, Ruffolo G, Fattouch J, Manfredi M, Russo E, Striano P, Carabotti M, Giallonardo AT, Severi C, Di Bonaventura C.
Date: 2021
Scope of interest: Epilepsy
Authors: Cerulli Irelli E, Barone FA, Mari L, Morano A, Orlando B, Salamone EM, Marchi A, Fanella M, Fattouch J, Placidi F, Giallonardo AT, Izzi F, Di Bonaventura C
Date: 2022
Scope of interest: Epilepsy
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide